NASDAQ:SHLT SHL Telemedicine (SHLT) Stock Price, News & Analysis $2.05 0.00 (0.00%) As of 04/16/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About SHL Telemedicine Stock (NASDAQ:SHLT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SHL Telemedicine alerts:Sign Up Key Stats Today's Range$2.05▼$2.0550-Day Range$1.92▼$2.5152-Week Range$1.85▼$5.98VolumeN/AAverage Volume10,021 shsMarket Capitalization$33.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use. It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.Read More… Receive SHLT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SHL Telemedicine and its competitors with MarketBeat's FREE daily newsletter. Email Address SHLT Stock News HeadlinesSHL Telemedicine to Delist ADRs from Nasdaq to Cut CostsMarch 11, 2025 | tipranks.comSHLT SHL Telemedicine Ltd.March 6, 2025 | seekingalpha.comVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.May 1, 2025 | Stansberry Research (Ad)SHL Telemedicine Ltd (SHLTN)January 23, 2025 | investing.comSHL Telemedicine (NASDAQ:SHLT) Stock Quotes, Forecast and News SummaryDecember 19, 2024 | benzinga.comDocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular CareDecember 18, 2024 | businesswire.comSHL Telemedicine (NASDAQ:SHLT) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comSHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli ActivityJune 20, 2024 | businesswire.comSee More Headlines SHLT Stock Analysis - Frequently Asked Questions How have SHLT shares performed this year? SHL Telemedicine's stock was trading at $2.65 at the beginning of the year. Since then, SHLT stock has decreased by 22.6% and is now trading at $2.05. View the best growth stocks for 2025 here. How do I buy shares of SHL Telemedicine? Shares of SHLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SHL Telemedicine own? Based on aggregate information from My MarketBeat watchlists, some other companies that SHL Telemedicine investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU). Company Calendar Today5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryN/A Current SymbolNASDAQ:SHLT CIK1166834 Webwww.shl-telemedicine.com Phone972-3-561-2212FaxN/AEmployees583Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.19 Current Ratio2.17 Quick Ratio1.98 Sales & Book Value Annual Sales$55.94 million Price / Sales0.60 Cash Flow$0.04 per share Price / Cash Flow54.03 Book Value$5.21 per share Price / Book0.39Miscellaneous Outstanding Shares16,393,000Free FloatN/AMarket Cap$33.61 million OptionableNot Optionable Beta0.11 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:SHLT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SHL Telemedicine Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SHL Telemedicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.